March 31, 2021

New Equilibrium Bio raises $10M from RA Capital for AI-powered quantum chemistry

New Equilibrium, the pioneer in rational drug design against intrinsically disordered proteins (IDPs), has closed a $10 million seed from RA Capital Management. New Equilibrium’s platform reveals previously-undetectable opportunities for structure-based design by learning biophysics with AI. The seed will scale up New Equilibrium’s R&D facility, expand the team, and accelerate programs targeting IDPs while exploring strategic partnerships.

New Equilibrium previously closed $350,000 in grants from the National Science Foundation and Massachusetts Life Sciences Center, as well as a $250,000 pre-seed from the Petri Life Sciences Incubator in Boston. Petri committed an additional $500,000 to the $10 million seed.